“…The classical TBD is dyskeratosis congenita (DC), which presents with mucocutaneous triad of reticular skin pigmentation, nail dysplasia, and oral leukoplakia, and is predominantly a pediatric disease. TBDs, especially in adults, have a broad phenotypic variability and can present with hematological (cytopenias), pulmonary (idiopathic pulmonary fibrosis), gastrointestinal (cirrhosis), or immunodeficiency phenotypes, and present with a variable constellation of symptoms, penetrance, inheritance, and age of onsets (genetic anticipation) [ 3 , 4 ]. Currently, the clinical approach to identify TBD patients includes telomere length measurement by flowFISH and/or identification of a pathogenic variant in one of the genes affecting telomere structural integrity and maintenance specifically, DKC1 , TERC , TERT , NOP10 , NHP2 , ACD , TINF2 , POT1 , CTC1 , STN1 , WRAP53 , RTEL1 , PARN , NAF1 , and ZCCHC8 [ 3 ].…”